GlassScriptPhysician profile
Deborah Schiller Schrager
NPI 1013021476
$3,278.41
in general payments reported to CMS, 2019-2025
26 companies · $563 in 2025
The $563 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $131 · 2021: $264 · 2022: $500 · 2023: $791 · 2024: $499 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.91 |
| Education | $128.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $672.58 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Sumitomo Pharma America, INC. | $611.21 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $440.60 | 2022-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $242.47 | 2019-2022 | |
| Millicent US INC | $135.47 | 2019-2025 | Intrarosa, Femlyv |
| Exeltis, USA INC. | $122.24 | 2024-2025 | Slynd |
| Myriad Women'S Health, INC. | $108.34 | 2023 | Myrisk |
| Mylan Pharmaceuticals INC. | $96.56 | 2019-2022 | |
| Evofem Biosciences, INC. | $92.34 | 2021-2022 | |
| Hologic Sales and Service, LLC | $85.90 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $81.31 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Daiichi Sankyo INC. | $80.48 | 2019-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $76.62 | 2023-2025 | |
| Urovant Sciences INC | $56.32 | 2022 | |
| Myovant Sciences INC. | $55.08 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $53.24 | 2019-2022 | |
| Organon LLC | $45.11 | 2023-2025 | Nexplanon |
| Aspira Women'S Health INC | $34.10 | 2020-2024 | Ova1 |
| Merck Sharp & Dohme LLC | $31.08 | 2019-2020 | |
| Davol INC. | $30.62 | 2021 | |
| Exact Sciences Corporation | $29.59 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $28.04 | 2019 | |
| Amag Pharmaceuticals, INC. | $23.44 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.08 | 2019 | |
| Avion Pharmaceuticals | $14.90 | 2020 | |
| Agile Therapeutics, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Schrager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.